We are pleased to present highlights of the latest advances in immunotherapy emerging from the 2026 ASCO Annual Meeting, May 31, 2026. (Thanks to Chinmay Jani, MD and Terri Holzen, PhD for compiling these scientific highlights) Final safety, efficacy and biomarker...
A Message from the President The pace of discovery in cancer immunotherapy continues to accelerate, creating both extraordinary opportunity and an urgent need for collaboration. For more than 40 years, the Society for Immunotherapy of Cancer (SITC) Annual Meeting has helped drive these...
We are pleased to present highlights of the latest advances in immunotherapy emerging from the 2026 ASCO Annual Meeting, May 30, 2026. (Thanks to Chinmay Jani, MD and Terri Holzen, PhD for compiling these scientific highlights) Tumor-specific MHC-II as a prospective...
We are pleased to present highlights of the latest advances in immunotherapy emerging from the 2026 ASCO Annual Meeting, May 29, 2026. (Thanks to Chinmay Jani, MD and Terri Holzen, PhD for compiling these scientific highlights) Azer-cel, an allogeneic CAR T cell, for relapsed...
The Society for Immunotherapy of Cancer (SITC) joined more than 60 cancer patient and provider organizations in signing onto a coalition letter led by the American Cancer Society Cancer Action Network (ACS CAN) directed to Secretary Kennedy in support of protecting the scientific integrity and...
Edited by Tanja D. de Gruijl, PhD and Howard Kaufman, MD, FACS While local immunotherapy has the potential to deliver high doses of immune potentiating agents with limited systemic toxicity, clinical development and implementation have been hindered by numerous challenges. This special...
The Society for Immunotherapy of Cancer (SITC) joined more than 50 organizations through One Voice Against Cancer (OVAC) in signing a coalition letter to Congress raising concerns about delays and disruptions in federal cancer research funding. View the letter in its entirety at this LINK . ...
SITC Announces Keynote Speakers Dr. Ton Schumacher and Dr. Catherine J. Wu at its 41 st Annual Meeting The largest cancer immunotherapy conference featuring the latest research in immuno-oncology MILWAUKEE, WI – The Society for Immunotherapy of Cancer (SITC) is proud to announce...
INSIDE THIS ISSUE: Letter from the Editor| JITC Editor Picks| JITC Meet-the-Editor Session at ASCO| Popular Articles Letter from the Editor Hello JITC Readers, This last month on April 29 th we celebrated with the International Union...
A Message from the President Staying current in immuno-oncology has never been more important—or more complex. With rapid advances across research, clinical practice, and regulation, access to timely, trusted education is essential. That’s where our brand-new Society for Immunotherapy of...
Join
Renew
Member Directory
My Profile
Email Sign-up
Volunteer
Support SITC
Contact Us